Free cash flow generation remains highly inconsistent, with margins swinging from a 14.8% peak in 2025Q3 to 1.7% in 2025Q4, largely driven by volatile working capital changes.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Cash from Operations | 208.36M | 185.08M | 107.3M | 111.22M | 8.74M | 62.39M | 203.26M | 100.1M | 98.44M | 94.47M | 90.88M | 73.96M | 75.69M | 102.35M | 64.69M | 80.65M | 62.4M | 85.15M | 56.88M | 45.94M | 35.73M | 63.84M | 20.3M | 45.41M | 48.56M | 34.78M | 52.23M | 33.59M | 28.5M | 35.2M | 52M |
| Operating CF Margin % | - | 12.25% | 8.27% | 9.74% | 0.81% | 6.17% | 20.73% | 10.05% | 10.04% | 9.8% | 9.84% | 8.16% | 8.68% | 12.97% | 8.5% | 10.43% | 8.66% | 12.74% | 8.98% | 7.68% | 6.35% | 11.77% | 3.89% | 9.6% | 10.6% | 8.28% | 11.3% | 7.63% | 6.46% | 7.59% | 13.46% |
| Operating CF Growth % | 436.81% | 72.48% | -3.52% | 1172.2% | -85.99% | -69.3% | 103.05% | 1.69% | 4.2% | 3.94% | 22.88% | -2.29% | -26.04% | 58.21% | -19.79% | 29.24% | -26.71% | 49.7% | 23.83% | 28.57% | -44.03% | 214.56% | -55.3% | -6.5% | 39.62% | -33.41% | 55.5% | 17.87% | -19.03% | -32.31% | 30.33% |
| Net Income | 123.67M | 122.61M | 102.09M | 65.29M | 19.98M | 139.09M | 41.99M | 67.98M | 58.7M | 55.68M | 50.54M | 53.14M | 53.37M | 64.61M | 57.96M | 64.07M | 52.7M | 40.05M | 36.37M | 45.45M | 36.74M | 28.64M | 23.97M | 19.95M | 16.44M | 13.2M | 10.22M | 8.38M | -6.4M | 37M | 29.3M |
| Depreciation & Amortization | 45.56M | 44.92M | 41.98M | 42.03M | 40.49M | 40.67M | 42.02M | 42.42M | 41.89M | 42.65M | 39.02M | 37.11M | 34.38M | 28.55M | 29.79M | 28.9M | 27.14M | 25.43M | 24.82M | 6.54M | 12.71M | 14.15M | 12.44M | 11.21M | 11.15M | 11.87M | 14.44M | 10.38M | 12.1M | 14.9M | 13.2M |
| Stock-Based Compensation | 3.37M | 4.4M | 4.16M | 2.78M | 2.61M | 2.62M | 2.45M | 1.88M | 1.78M | 1.68M | 509K | 1.98M | 2.02M | 2.3M | 2.37M | 2.75M | 321K | 1.13M | 2.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 5.12M | 6.48M | 17.94M | 5.77M | 6M | -6.29M | -10.59M | 4.05M | 718K | -4.71M | 4.79M | -648K | -1.43M | -2.4M | 558K | 1.99M | 3.5M | 1.38M | -4.49M | 10.69M | -1.72M | -2.32M | -1.16M | -3.49M | -1.84M | -720K | -712K | 3.53M | -10.5M | -4.5M | 0 |
| Other Non-Cash Items | -20.15M | -26.72M | -33.15M | -22.05M | 13.37M | -72.95M | 16.99M | -20.17M | -653K | 5.89M | 6.57M | 6.68M | 9.46M | 1.02M | -6.48M | 2.83M | -4.73M | -2.58M | -3.25M | -8.56M | -5.86M | 3.21M | 2.22M | 158K | 6.63M | 1.23M | 5.42M | 2.2M | 200K | 100K | 1.7M |
| Working Capital Changes | 48.28M | 33.4M | -25.72M | 17.4M | -73.7M | -40.74M | 110.4M | 3.95M | -4M | -6.72M | -10.55M | -24.3M | -22.11M | 8.28M | -19.5M | -19.89M | -16.53M | 19.74M | 1.28M | 8.47M | -384K | 20.16M | -17.18M | 17.58M | 16.2M | 9.2M | 22.86M | 9.1M | 29.5M | -13.9M | 7.8M |
| Change in Receivables | 4M | -3.68M | -26.44M | -8.56M | -3.86M | 4.09M | 4.53M | 4.3M | -9.4M | -9.49M | -4.4M | -11.84M | -5.21M | -13.78M | -7.26M | 5.03M | -15.82M | 15.97M | 18.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -1.07M | 1.24M | -599K | -298K | 1.49M | 199K | -1.25M | 29K | -317K | 355K | 60K | -441K | 19K | -486K | 759K | 434K | -372K | -251K | -488K | -103K | -754K | -364K | -218K | -319K | -379K | -51K | 718K | -803K | -300K | -400K | -500K |
| Change in Payables | -275K | -2.73M | 6.3M | 2.24M | -5.53M | -2.08M | 1.43M | -856K | 3.47M | -2.62M | -1.53M | 4.25M | 2.83M | 2.5M | 831K | -1.11M | -352K | -2.9M | 391K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -40.75M | -33.86M | -236.69M | -17.57M | -5.98M | -65.89M | -63.88M | -14.27M | -33.66M | -9.56M | -81.48M | -63.85M | -57.51M | -56.3M | -31.23M | -31.75M | -46.35M | -39.19M | -11.12M | -118.95M | -42.27M | -20.04M | -8.57M | -17.43M | 3.05M | 4.21M | -50.85M | -32.96M | -24.9M | -51.7M | -64.4M |
| Capital Expenditures | -39.95M | -36.45M | -27.6M | -27.9M | -30.2M | -39.4M | -21.87M | -26.4M | -29.77M | -32.35M | -62.6M | -58.42M | -53.3M | -43.44M | -22M | -23.6M | -32.84M | -44.06M | -42.66M | -17.76M | -37.4M | -18.41M | -22.74M | -24.43M | -12.82M | -5.34M | -6.72M | -22M | -24M | -34.8M | -70M |
| CapEx % of Revenue | 2.62% | 2.41% | 2.13% | 2.44% | 2.81% | 3.9% | 2.23% | 2.65% | 3.04% | 3.36% | 6.78% | 6.44% | 6.11% | 5.51% | 2.89% | 3.05% | 4.56% | 6.59% | 6.74% | 2.97% | 6.64% | 3.39% | 4.36% | 5.17% | 2.8% | 1.27% | 1.45% | 5% | 5.44% | 7.51% | 18.12% |
| Acquisitions | -3.53M | -5.63M | -228.1M | -7.36M | 0 | -29.06M | -203K | -15.81M | 3.33M | -246K | -1.28M | -674K | -1.98M | -21M | -7.5M | -7.5M | -14.34M | 384K | 1.19M | -91.07M | 2.79M | 1.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 505K | 512K | 2.09M | -201K | 8.05M | 8.84M | 2.06M | -4.08M | 1.55M | 4.08M | -3.62M | 8.21M | 11.14M | 19.9M | 47.32M | 11.33M | 48.98M | 25.83M | 31.52M | -21.92M | -4.67M | 318K | 22.36M | 6.52M | 2.19M | 2.32M | -36.88M | 7.04M | 3.4M | -17.5M | 18.3M |
| Cash from Financing | -177.44M | -135.96M | 100.34M | -42.55M | -47.64M | -35.26M | -41.89M | -79.75M | -77.27M | -49.07M | -27.13M | -41.67M | -30.12M | -31.04M | -27.77M | -16.38M | -26.6M | -55.98M | 890K | 24.71M | -3.65M | -23.53M | -15.02M | -34.56M | -24.88M | -6.81M | 4.58M | -9.21M | -8.2M | 31.8M | 9.5M |
| Debt Issued (Net) | -134M | -97M | 136.14M | -4.99M | -4.7M | -4.42M | -14.17M | -48.92M | -48.7M | -23.48M | -3.28M | 106.91M | -2.44M | 0 | 0 | -95K | 21K | -50.3M | 42.63M | -2.69M | -2.45M | -2.26M | -3.82M | -6.72M | -25.33M | -8.88M | 8.41M | -8.89M | -3.6M | 38.2M | 22.7M |
| Equity Issued (Net) | -4.13M | -516K | 766K | -2.17M | -7.79M | 2.6M | 1.7M | 1.47M | 2M | 2.52M | 2.58M | -119.9M | 434K | -3.71M | 13.41M | 8.39M | -3.29M | 15.39M | 6.66M | 5.98M | 5.67M | 1.43M | 3.02M | 909K | 1.41M | 4.64M | -2.92M | 734K | 1M | 2.3M | 1.4M |
| Dividends Paid | -39.23M | -38.7M | -36.96M | -35.56M | -34.6M | -32.03M | -31.92M | -31.21M | -29.83M | -28.24M | -25.8M | -30.07M | -27.37M | -26.14M | -39.52M | -24.62M | -23.45M | -22.18M | -19.88M | -9.77M | -8.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.4M | -21M | -17.5M |
| Share Repurchases | -29.33M | -14.73M | -13.5M | -2.48M | -9.9M | -836K | -53K | -872K | -867K | 0 | -8.2M | -130.54M | -7M | -4.7M | 0 | 0 | -5.94M | 0 | 0 | 0 | 0 | -6.72M | -4.38M | -258K | 0 | 0 | -3.31M | 0 | 0 | 0 | 0 |
| Other Financing | -92K | 265K | 402K | 169K | -554K | -1.42M | 2.5M | -1.09M | -749K | 120K | -635K | 1.39M | -748K | -1.2M | -1.67M | -52K | 124K | 1.11M | -28.52M | 31.2M | 1.24M | -15.98M | -14.22M | -28.75M | -955K | -2.56M | -919K | -1.05M | -200K | 12.3M | 2.9M |
| Net Change in Cash | -9.79M | 15.27M | -29.05M | 51.1M | -44.88M | -38.76M | 97.49M | 6.09M | -12.5M | 35.83M | -17.73M | -31.56M | -11.94M | 15M | 5.69M | 32.53M | -10.54M | -10.01M | 46.65M | -48.3M | -10.19M | 20.27M | -3.3M | -6.59M | 26.73M | 32.19M | 5.96M | -8.58M | -8.2M | 31.8M | 9.5M |
| Free Cash Flow | 168.41M | 148.63M | 79.7M | 83.31M | -21.46M | 23M | 181.39M | 73.7M | 68.66M | 62.12M | 28.28M | 15.55M | 22.4M | 58.91M | 42.69M | 57.06M | 29.57M | 41.09M | 14.22M | 28.17M | -1.67M | 45.43M | -2.45M | 20.98M | 35.74M | 29.44M | 45.51M | 11.59M | 4.5M | 400K | -18M |
| FCF Margin % | 11.05% | 9.84% | 6.14% | 7.3% | -2% | 2.27% | 18.5% | 7.4% | 7% | 6.44% | 3.06% | 1.71% | 2.57% | 7.47% | 5.61% | 7.38% | 4.1% | 6.15% | 2.25% | 4.71% | -0.3% | 8.38% | -0.47% | 4.44% | 7.8% | 7.01% | 9.84% | 2.63% | 1.02% | 0.09% | -4.66% |
| FCF Growth % | 85.87% | 86.48% | -4.34% | 488.27% | -193.32% | -87.32% | 146.1% | 7.34% | 10.53% | 119.65% | 81.91% | -30.58% | -61.98% | 37.99% | -25.18% | 92.98% | -28.04% | 188.91% | -49.52% | 1784.93% | -103.68% | 1957.36% | -111.66% | -41.3% | 21.42% | -35.32% | 292.74% | 157.51% | 1025% | 102.22% | -271.43% |
| FCF per Share | 10.68 | 9.50 | 5.11 | 5.42 | -1.39 | 1.49 | 11.80 | 4.80 | 4.51 | 4.08 | 1.86 | 1.07 | 1.57 | 3.53 | 2.57 | 3.48 | 2.16 | 3.03 | 1.08 | 2.17 | -0.13 | 3.55 | -0.20 | 1.74 | 2.99 | 2.52 | 3.97 | 1.01 | 0.40 | 0.04 | -1.82 |
| FCF Conversion (FCF/Net Income) | 1.36x | 1.54x | 1.05x | 1.66x | 0.39x | 0.45x | 4.85x | 1.47x | 1.67x | 1.68x | 1.80x | 1.39x | 1.42x | 1.58x | 1.09x | 1.24x | 1.18x | 2.13x | 1.56x | 1.01x | 0.97x | 2.23x | 0.85x | 2.28x | 2.95x | 2.64x | 5.11x | 4.01x | -4.45x | 0.95x | 1.77x |
| Interest Paid | 0 | 0 | 3.42M | 290K | 493K | 845K | 1.43M | 3.12M | 4.9M | 5.18M | 4.53M | 2.96M | 2.24M | 497K | 383K | 501K | 658K | 869K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 17.52M | 14.57M | 8.77M | 22.88M | 16.52M | 20.89M | 9.18M | 23.55M | 27.67M | 29.18M | 36.64M | 34.27M | 34.14M | 40.8M | 22.97M | 21.59M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Working capital volatility
Based on reported financial statements, NHC's OCF/NI ratio has fluctuated wildly, reaching a high of 2.65 in 2025Q2 before dropping to 0.68 in 2025Q4, which suggests that net income is an unreliable proxy for the company's actual ability to generate cash from core operations.
The significant variance between net income and operating cash flow indicates that non-cash items and timing differences in revenue recognition are heavily influencing reported results. Investors should monitor whether this decoupling reflects persistent issues in billing cycles or the impact of lumpy incentive payments that distort quarterly performance.
As indicated by recent quarterly data, NHC's free cash flow margin has exhibited extreme volatility, ranging from a low of 1.2% in 2024Q1 to a peak of 14.8% in 2025Q3, highlighting a lack of consistent cash generation despite the company's stable operational footprint.
This erratic FCF trajectory suggests that the company's cash flow is highly sensitive to working capital fluctuations rather than steady operational growth. The inability to maintain a consistent FCF margin may imply that the business model is susceptible to sudden shifts in reimbursement timing or unexpected spikes in operating expenses.
According to the cash flow statements, working capital changes have been a primary driver of liquidity, with a $29.9M inflow in 2025Q3 contrasting sharply with a $32.7M outflow in 2024Q4, suggesting that the company's cash position is heavily dependent on the timing of collections and payables.
The frequent and large swings in working capital indicate that NHC's cash flow is not purely reflective of operational efficiency but is instead subject to the inherent complexities of multi-payer billing. This volatility warrants further investigation into whether the company is experiencing delays in receiving government reimbursements or if internal management of accounts receivable is becoming less predictable.
Based on the provided figures, NHC consistently utilizes cash for dividends and modest share repurchases, with dividend payments remaining steady at approximately $9.9M per quarter throughout 2025, reflecting a commitment to shareholder returns despite the underlying volatility in operational cash flow generation.
The company's disciplined approach to capital deployment suggests that management prioritizes dividend stability over aggressive reinvestment or large-scale acquisitions. While this provides a cushion for shareholders, it also raises questions about whether the company is missing opportunities to deploy capital into higher-growth areas of the healthcare continuum.
Quick answers to the most common questions about buying NHC stock.
National HealthCare Corporation (NHC) generated $185.1M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
National HealthCare Corporation (NHC) generated $148.6M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
National HealthCare Corporation (NHC) spent $36.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, National HealthCare Corporation (NHC) returned $38.7M to shareholders via cash dividends and spent $14.7M on share repurchases. This shows the company's commitment to returning capital to its equity investors.